重大事件
即時報告
8-K
2026-06-03
Inhibrx Biosciences 提交8-K 報告股東投票事項 未披露具體結果
AI 繁中摘要
Inhibrx Biosciences, Inc. 於2026年6月3日向 SEC 提交了一份 8-K 表格，報告近期股東投票事項（Item 5.07）。是次申報未披露具體投票結果細節，僅列出公司已將若干事宜提交證券持有人表決。公司總部位於加州拉荷亞，專注生物製藥（SIC 2836）。投資者應留意後續補充文件或10-Q/10-K中可能公布的投票結果及相關影響。 🔍
展開英文正文
EDGAR Filing Documents for 0002007919-26-000030 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0002007919-26-000030 Filing Date 2026-06-03 Accepted 2026-06-03 16:02:12 Documents 11 Period of Report 2026-06-03 Items Item 5.07: Submission of Matters to a Vote of Security Holders Interactive Data Document Format Files Seq Description Document Type Size 1 8-K inhibrx-20260603.htm iXBRL 8-K 29783 Complete submission text file 0002007919-26-000030.txt 152258 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inhibrx-20260603.xsd EX-101.SCH 1809 3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inhibrx-20260603_lab.xml EX-101.LAB 23449 4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inhibrx-20260603_pre.xml EX-101.PRE 13596 14 EXTRACTED XBRL INSTANCE DOCUMENT inhibrx-20260603_htm.xml XML 2929 Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220 Inhibrx Biosciences, Inc. (Filer) CIK: 0002007919 (see all company filings) EIN.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-42031 | Film No.: 261060531 SIC: 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)